March 30, 2021
Article
Increased expansion and availability of naloxone may prove to be a monumental aspect of the public health response to the opioid crisis.
March 24, 2021
The FDA has approved the submission of a supplemental new drug application (sNDA) that expands the use of bupivacaine liposome injectable suspension to include patients aged 6 years and older for single-dose infiltration as a postsurgical local analgesia.
March 18, 2021
The study results reiterate the importance of interventions to lower prescribing rates of potentially inappropriate drugs among older adults.
March 16, 2021
Preliminary research by the American Heart Association suggests the opioid epidemic in the United States may have led to an increase in the number of strokes due to bacterial infections of the heart (infective endocarditis).
March 01, 2021
Pharmacy's History: German chemist Felix Hoffmann worked on the substances at Bayer during a 2-Week period in 1897.
February 25, 2021
Investigators found an average difference of 12% in the range of fracture-associated drug prescribing when comparing hospital referral regions.
February 24, 2021
This activity is supported by an independent medical education grant from AcelRx Pharmaceuticals, Inc.
February 22, 2021
Health system employee’s dismissal is based on medicinal use of marijuana under 2016 law.
February 17, 2021
The study is the first of its kind to focus on the effect of cannabis on blood pressure, heart rate, and metabolic parameters in adults 60 years of age and older with hypertension.
February 16, 2021
Opioid overdoses are increasing, and pharmacists can play an integral role in prevention.
